Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 109   

Articles published

4502 4,783.00 +3.50 (0.07%)
price chart
Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk
Lilly, which co-promoted Actos from 1999 to 2006, was not immediately available to comment. The company has previously said it will be indemnified by Takeda for its losses and expenses from the litigation based on the terms of its agreement with Takeda.
Takeda Announces Completion of the Post-Marketing Commitment to Submit ...  MarketWatch
Related articles »  
Eye-Catching Stocks - Amadeus IT Holding SA (AMADY),Takeda ...
Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPPY) is engaged in supplying pharmaceutical products worldwide. The company provides products in various therapeutic areas, including cardiovascular and metabolic, oncology, central nervous system, ...
Takeda Pharmaceutical Co, Eli Lilly lose $9 bn damages over Actos drug
Takeda Pharmaceutical Co Ltd and Eli Lilly & Co lost a $9 billion punitive damage award by a US jury for hiding cancer risks associated with their Actos diabetes drug, Reuters reported.
Active Movers -NOVUS ACQ & DEV CORP (OTCMKTS:NDEV),Takeda ...
Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPPY)is engaged in supplying pharmaceutical products worldwide. The company provides products in various therapeutic areas, including cardiovascular and metabolic, oncology, central nervous system, ...
Related articles »  
Penny Stocks in Focus: Cellceutix Corp (OTCMKTS:CTIX), Takeda ...
Cellceutix Corp (OTCMKTS:CTIX),a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, reported that the Company has just received the final toxicology report for Brilacidin-OM.
UPDATE 1-Takeda, Lilly lose bid to overturn $9 bln award for hiding cancer risk
Takeda shares muted, up 0.4 pct (Adds Takeda comment, Actos study result, share price, other details). Aug 28 (Reuters) - Takeda Pharmaceutical Co Ltd and Eli Lilly & Co lost a bid to overturn a combined $9 billion punitive damage award by a U.S. jury ...
Eli Lilly, Takeda To Pay $9 Billion In Punitive Damages
Eli Lilly & Co (LLY) and Takeda Pharmaceutical Co Ltd today failed to overturn a $9 billion punitive damage award. The companies had been taken to court by plaintiffs who argued the two deliberately misled patients and doctors as to the risks ...
Takeda, Lilly Lose Bid to Overturn $9 Billion Actos Award
Takeda Pharmaceutical (4502) Co. and Eli Lilly (LLY:US) & Co. lost a bid to have a judge throw out a combined $9 billion punitive-damage award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine.
J&J And Bristol-Myers Changing The Myeloma Drug Landscape
Multiple myeloma is a serious, life-threatening disease and many drug-makers have put huge R&D efforts into developing a cure.
Takeda Challenges Claim Construction Rule At High Court
Law360, New York (August 29, 2014, 5:07 PM ET) -- Takeda Pharmaceutical Co. Ltd. has asked the U.S. Supreme Court to nix the Federal Circuit's reversal of an infringement finding against Zydus Pharmaceuticals USA Inc. over its planned generic of the ...